Original Research
Published on 15 May 2020
Elevated Bone Hardness Under Denosumab Treatment, With Persisting Lower Osteocyte Viability During Discontinuation
in Bone Research
Frontiers in Endocrinology
doi 10.3389/fendo.2020.00250
- 9,128 views
- 37 citations
